Chengdu Kanghong Pharmaceutical Group Co. Ltd. at its Extraordinary General Meeting of 2022 held on 03 August 2023, approved Election and nomination of Wang Lin Zhang Zhirong and Yin Jinqun as non-independent directors, Election and nomination of Zhou Demin Deng Hongguang and Xu Nan as independent directors and Election of Cheng Yanmei and Gong Wenxian as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.56 CNY | -1.57% | -4.20% | +22.34% |
Apr. 29 | Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug | MT |
Apr. 29 | Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.34% | 2.92B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- 002773 Stock
- News Chengdu Kanghong Pharmaceutical Group Co., Ltd
- Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Executive Changes